Related Experiment Video
Updated: Jun 10, 2026

An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause
Published on: August 13, 2019
Natural compounds with aromatase inhibitory activity: an update
Marcy J Balunas1, A Douglas Kinghorn
1Division of Medicinal Chemistry, Department of Pharmaceutical Sciences, School of Pharmacy, Storrs, CT 06269, USA. marcy.balunas@uconn.edu
Researchers are exploring natural compounds as novel aromatase inhibitors for breast cancer treatment. These compounds offer a promising alternative to synthetic drugs, potentially reducing side effects and targeting specific cancer promoters.
Area of Science:
- Biochemistry
- Pharmacology
- Oncology
Background:
- Current synthetic aromatase inhibitors are used for hormone-receptor positive breast cancer in postmenopausal women.
- These treatments can cause adverse side effects, necessitating the search for alternatives.
- Aromatase inhibitors targeting breast-specific promoters (I.3 and II) are of particular interest.
Purpose of the Study:
- To review recent investigations on natural compounds as aromatase inhibitors.
- To evaluate natural compounds for promoter-specific aromatase inhibition.
- To assess natural compounds as potential aromatase inducers.
Main Methods:
- Review of noncellular, cellular, and in vivo studies published in the last two years.
- Analysis of studies focusing on promoter-specific aromatase inhibition.
- Examination of research on natural compounds as aromatase inducers.
Main Results:
- Numerous natural compounds have demonstrated aromatase inhibitory activity.
- Evidence suggests potential for promoter-specific activity of natural compounds.
- Some natural compounds may also act as aromatase inducers.
Conclusions:
- Natural compounds represent a promising area for developing new aromatase inhibitors.
- Further research into promoter-specific natural compounds could lead to more targeted breast cancer therapies.
- Natural compounds may offer a safer alternative to existing synthetic treatments.
Related Concept Videos
Aromatic Compounds: Overview
In 1825, Faraday isolated benzene...
Enzyme Inhibition
Cholinergic Antagonists: Chemistry and Structure-Activity Relationship
Adrenergic Agonists: Chemistry and Structure-Activity Relationship
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of the aromatic...
Transducer Mechanism: Nuclear Receptors
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
